Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Cipla
McKinsey
Express Scripts
Boehringer Ingelheim
Harvard Business School
Fish and Richardson
Dow
Johnson and Johnson
Colorcon

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206867

« Back to Dashboard

NDA 206867 describes ATHENTIA NEXT, which is a drug marketed by Aurobindo Pharma Ltd and is included in one NDA. It is available from two suppliers. Additional details are available on the ATHENTIA NEXT profile page.

The generic ingredient in ATHENTIA NEXT is levonorgestrel. There are twenty drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
Summary for 206867
Tradename:ATHENTIA NEXT
Applicant:Aurobindo Pharma Ltd
Ingredient:levonorgestrel
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 206867
Suppliers and Packaging for NDA: 206867
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ATHENTIA NEXT levonorgestrel TABLET;ORAL 206867 ANDA Afaxys Pharma, LLC 50102-211 N 50102-211-11
ATHENTIA NEXT levonorgestrel TABLET;ORAL 206867 ANDA Afaxys Pharma, LLC 50102-211 N 50102-211-16

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength1.5MG
Approval Date:Dec 8, 2015TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Accenture
Cipla
AstraZeneca
Teva
Fuji
Covington
Baxter
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot